Search Within

Alan Loh Ho

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (32)
  2. Meeting Abstract (25)
  3. Editorial (1)
  4. Research Letter (1)
Groups
  1. Department of Medicine (59)
  2. Epidemiology and Biostatistics (59)
  3. Head and Neck Service (59)
  4. Solid Tumor Oncology Division (59)
  5. Biostatistics Service (50)
  6. Department of Pathology and Laboratory Medicine (40)

More Groups

People
  1. David Pfister (30)
  2. Eric Sherman (29)
  3. Lara Dunn (21)
  4. Nora Katabi (19)
  5. Sofia Haque (18)
  6. James Fagin (16)

More People

Years
  1. 2024 (8)
  2. 2023 (7)
  3. 2022 (4)
  4. 2021 (4)
  5. 2020 (4)
  6. 2019 (7)

More Years

Publications
  1. Journal of Clinical Oncology (21)
  2. Annals of Oncology (5)
  3. Clinical Cancer Research (4)
  4. International Journal of Radiation Oncology, Biology, Physics (4)
  5. European Journal of Nuclear Medicine and Molecular Imaging (3)
  6. American Journal of Surgical Pathology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. Oxford University Press (7)
  3. American Association for Cancer Research (6)
  4. Springer (6)
  5. Elsevier Inc. (5)
  6. Nature Publishing Group (3)

More Publishers

Results (59)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictors of outcome in adenoid cystic carcinoma of salivary glands: A clinicopathologic study with correlation between MYB fusion and protein expression
    Journal Article

    Xu, B.; Drill, E.; Ho, A.; Ho, A.; Dunn, L.; Prieto-Granada, C. N.; Chan, T.; Ganly, I.; Ghossein, R.; Katabi, N.
    American Journal of Surgical Pathology (2017)

    Fulltext@MSK | Save
  • The PARP inhibitor veliparib can be safely added to bendamustine and rituximab and has preliminary evidence of activity in B-cell lymphoma
    Journal Article

    Soumerai, J. D.; Zelenetz, A. D.; Moskowitz, C. H.; Palomba, M. L.; Hamlin, P. A. Jr; Noy, A.; Straus, D. J.; Moskowitz, A. J.; Younes, A.; Matasar, M. J.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Phase II study of regorafenib in progressive, recurrent/metastatic adenoid cystic carcinoma
    Meeting Abstract

    Ho, A. L.; Sherman, E. J.; Baxi, S. S.; Haque, S.; Ni, A.; Antonescu, C. R.; Katabi, N.; Morris, L. G.; Chan, T. A. T.; Pfister, D. G.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Enhancing radioiodine (RAI) incorporation into BRAF(V600E)-mutant, RAI-refractory thyroid cancers with the BRAF inhibitor vemurafenib: A pilot study
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Baxi, S. S.; Grewal, R. K.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M.; Fish, S.; Boucai, L.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • OncoKB: Annotation of the oncogenic effect and treatment implications of somatic mutations in cancer
    Meeting Abstract

    Chakravarty, D.; Phillips, S. M.; Gao, J.; Kundra, R.; Zhang, H.; Rudolph, J. E.; Yaeger, R. D.; Soumerai, T.; Nissan, M. H.; Chandarlapaty, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma
    Journal Article

    Ho, A. L.; Dunn, L.; Sherman, E. J.; Fury, M. G.; Baxi, S. S.; Chandramohan, R.; Dogan, S.; Morris, L. G. T.; Cullen, G. D.; Haque, S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast cancer
    Journal Article

    Dalin, M. G.; Desrichard, A.; Katabi, N.; Makarov, V.; Walsh, L. A.; Lee, K. W.; Wang, Q.; Armenia, J.; West, L.; Dogan, S.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • What hides behind the MASC: Clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)
    Journal Article

    Drilon, A.; Li, G.; Dogan, S.; Gounder, M.; Shen, R.; Arcila, M.; Wang, L.; Hyman, D. M.; Hechtman, J.; Wei, G.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Employment and quality of life (QOL) in human papillomavirus-related (HPV+) oropharynx cancer treated with definitive chemoradiation (CTRT)
    Meeting Abstract

    Baxi, S. S.; Xiao, H.; Fury, M. G.; Atoria, C. L.; Dunn, L.; Salz, T.; Sherman, E. J.; Ho, A. L.; Lee, N. Y.; Pfister, D. G.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors
    Journal Article

    Hyman, D. M.; Snyder, A. E.; Carvajal, R. D.; Gerecitano, J. F.; Voss, M. H.; Ho, A. L.; Konner, J.; Winkelmann, J. L.; Stasi, M. A.; Monson, K. R.; more...
    Cancer Chemotherapy and Pharmacology (2015)

    Fulltext@MSK | Save